CAP and AMP officials weigh in on plans to push for a legislative- or CLIA-based approach to future LDT oversight
Recent cases involve another fraud related to finger prick blood testing, as well as alleged malpractice and discrimination.
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.
In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.
In this month’s roundup of cases involving labs, Labcorp gets one lawsuit tossed and settles another.
In this month’s Labs in Court roundup, a medical device company and genetic testing company each win key victories.
Key cases over the last month include a CGx testing kickback scheme, false billing, and violations of a non-compete clause and HIPAA.
Key cases over the past month were the usual FCA-related fare, apart from a dismissed sex discrimination case.
In this month’s roundup of key lab-related cases, a bizarre twist in the Theranos saga leads to a slim chance of a mistrial.
This month’s key lab cases involve false billing of urine drug and PGx tests and two lawsuits that were tossed.
In this Labs in Court monthly roundup, the Texas-based pathology lab was accused of falsely billing Medicare for unnecessary tests on biopsy specimens.
In this month’s Labs in Court roundup, BioReference pays big to settle kickback allegations, among several other kickback-related cases.
In this month’s Labs in Court roundup, Arrayit’s former president loses his bid to have EKRA charges dismissed, and more.
